Cephalon, Teva Settle Patent Dispute Over Provigil
Cephalon Inc. and Israeli generic-drug maker Teva Pharmaceutical Industries Ltd. have struck a deal to put an end to their patent disputes involving Cephalon's narcolepsy drug Provigil, the two companies said....To view the full article, register now.
Already a subscriber? Click here to view full article